Cantor Fitzgerald Raises Pfizer (PFE) PT to $27 Amid Shifting Obesity Data Focus

4 days ago 6

Maham Fatima

Sat, January 31, 2026 astatine 6:49 AM CST 2 min read

Pfizer Inc. (NYSE:PFE) is 1 of the most undervalued ample headdress stocks to put successful now. On January 27, Cantor Fitzgerald raised the firm’s terms people connected Pfizer to $27 from $24 and maintained a Neutral standing connected the shares. With 2026 guidance already established and lone humble beat-and-raise imaginable anticipated, the steadfast expects a comparatively quiescent net call, shifting capitalist absorption toward the timing and framing of VESPER-3 obesity data.

Additionally, Cantor Fitzgerald suggested that incremental updates regarding the Lyme illness vaccine, mevro for prostate cancer, and sigvotatug vedotin for non-small compartment lung crab volition apt beryllium much influential than the Q4 2025 results.

Time to Go Short connected Pfizer (PFE)?

In different news, connected January 10, Pfizer announced affirmative results from Cohort 3 of the pivotal Phase 3 BREAKWATER trial, evaluating BRAFTOVI (encorafenib) successful operation with cetuximab and FOLFIRI for patients with antecedently untreated BRAF V600E-mutant metastatic colorectal cancer. The survey showed a statistically important and clinically meaningful confirmed nonsubjective effect complaint of 64.4% compared to 39.2% for patients receiving the standard-of-care FOLFIRI regimen. These findings suggest that the BRAFTOVI operation provides a durable effect and imaginable flexibility successful chemotherapy backbones for this assertive cancer.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products successful the US and internationally. The institution offers medicines and vaccines successful assorted therapeutic areas.

While we admit the imaginable of PFE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.